The comparison of effects of ozone and corticosteroids injection in treatment of shoulder inflammatory diseases
- Conditions
- Shoulder tendinopathy.Impingement syndrome of shoulder
- Registration Number
- IRCT2016122424572N4
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Age between 20 and 80 years;
Shoulder tendinopathy as positive result of specific test like Neer & Hawkins test;
Visual Analogue Scale (VAS) > 4;
The willingness of patients to participate in research projects;
The absence history of rotator cuff tear, diabetes, coagulation disorders, fractures, rheumatologic diseases, tumors, and infections;
Not having shoulder injection in last 3 months;
The absence of intraarticular injection contraindications like anticoagulant medications consumption;
The absence of corticosteroid and lidocaine injection contraindications such as allergy reaction to these medications and skin infection at the injection site;
The absence of ozone injection contraindications such as G6PDD, uncontrolled hyperthyroid, the first 3 months of pregnancy, leukemia.
The willingness of patients to exit from the study at any stage of the project;
Noncoming patient for follow-up and evaluation during the follow-up study;
Daily use of any type of pain medication by patients for the duration of the study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of symptoms. Timepoint: Zero, two weeks and two months after. Method of measurement: Visual Analog Scale (VAS).;Shoulder Pain and Disability Index. Timepoint: Zero, two weeks and two months after. Method of measurement: SPADI questionnaire.;The severity of symptoms and functional limitations. Timepoint: Zero, two weeks and two months after. Method of measurement: Constant score questionnaire.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: Two weeks and two months after. Method of measurement: Physical examination.